Functional Analysis of Platelet-Activating Factor in the Retinal Pigment Epithelial Cells and Choroidal Endothelial Cells

被引:10
作者
He, Yu-Guang [1 ]
Wang, Hao [1 ]
Zhao, Biren [1 ]
Hsu, Maylon [1 ]
Liao, David [1 ]
Owens, John [2 ]
Johnston, John [3 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
关键词
Choroidal endothelial cells; Choroidal neovascularization; Platelet-activating factor; Retinal pigment epithelial cells; GROWTH-FACTOR; MACULAR DEGENERATION; LIPID MEDIATORS; FACTOR RECEPTOR; IN-VIVO; ANGIOGENESIS; EXPRESSION; NEOVASCULARIZATION; VEGF; PREVALENCE;
D O I
10.3109/02713680903231135
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate the function of platelet-activating factor (PAF) in cultured retinal pigment epithelial (RPE) and choroidal endothelial (CE) cells. Methods: The in vitro and in vivo expression of PAF-receptors (PAF-R) on both these cells was determined. The production of PAF by RPE cells was also determined. The effect of PAF on the proliferation, migration, permeability, and apoptosis of CE cells was examined, and the modulation of PAF on the VEGF level in RPE cells was assessed. Results: PAF-R was present in both types of cells in vitro, as well as in RPE and choroid in vivo. Cultured RPE cells synthesized PAF. PAF stimulated CE cell migration and permeability but not the proliferation. PAF also increased the VEGF level in RPE cells. Conclusions: Similar to VEGF, PAF stimulates CE cell migration and permeability. It also up regulates VEGF level in RPE cells. PAF may be involved in the pathogenesis of choroidal neovascularization.
引用
收藏
页码:957 / 965
页数:9
相关论文
共 37 条
[1]   Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration [J].
Avery, RL ;
Pieramici, DJ ;
Rabena, MD ;
Castellarin, AA ;
Nasir, MA ;
Giust, MJ .
OPHTHALMOLOGY, 2006, 113 (03) :363-372
[2]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[3]  
Bratton D., 1989, Platelet Activating Factor and Human Disease, P23
[4]   AGE-RELATED MACULAR DEGENERATION [J].
BRESSLER, NM ;
BRESSLER, SB ;
FINE, SL .
SURVEY OF OPHTHALMOLOGY, 1988, 32 (06) :375-413
[5]  
BUSSOLINO F, 1986, J BIOL CHEM, V261, P6502
[6]  
CAMUSSI G, 1995, J IMMUNOL, V154, P6492
[7]  
Camussi G, 1997, J IMMUNOL, V158, P1302
[8]   Clinicopathological correlation of primary and recurrent choroidal neovascularisation following surgical excision in age related macular degeneration [J].
Castellarin, AA ;
Nasir, MA ;
Sugino, IK ;
Zarbin, MA .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (05) :480-487
[9]   A PLATELET-ACTIVATING-FACTOR ANTAGONIST REDUCES CORNEAL ALLOGRAFT INFLAMMATION AND NEOVASCULARIZATION [J].
COHEN, RA ;
GEBHARDT, BM ;
BAZAN, NG .
CURRENT EYE RESEARCH, 1994, 13 (02) :139-144
[10]  
FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640